FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801690382> ?p ?o ?g. }

• W2801690382 endingPage "6" @default.
• W2801690382 startingPage "1" @default.
• W2801690382 abstract "To describe the efficacy and safety of ketogenic diet (KD) for convulsive refractory status epilepticus (RSE).RSE patients treated with KD at the 6/11 participating institutions of the pediatric Status Epilepticus Research Group from January-2011 to December-2016 were included. Patients receiving KD prior to the index RSE episode were excluded. RSE was defined as failure of ≥2 anti-seizure medications, including at least one non-benzodiazepine drug. Ketosis was defined as serum beta-hydroxybutyrate levels >20 mg/dl (1.9 mmol/l). Outcomes included proportion of patients with electrographic (EEG) seizure resolution within 7 days of starting KD, defined as absence of seizures and ≥50% suppression below 10 μV on longitudinal bipolar montage (suppression-burst ratio ≥50%); time to start KD after onset of RSE; time to achieve ketosis after starting KD; and the proportion of patients weaned off continuous infusions 2 weeks after KD initiation. Treatment-emergent adverse effects (TEAEs) were also recorded.Fourteen patients received KD for treatment of RSE (median age 4.7 years, interquartile range [IQR] 5.6). KD was started via enteral route in 11/14 (78.6%) patients. KD was initiated a median of 13 days (IQR 12.5) after the onset of RSE, at 4:1 ratio in 8/14 (57.1%) patients. Ketosis was achieved within a median of 2 days (IQR 2.0) after starting KD. EEG seizure resolution was achieved within 7 days of starting KD in 10/14 (71.4%) patients. Also, 11/14 (78.6%) patients were weaned off their continuous infusions within 2 weeks of starting KD. TEAEs, potentially attributable to KD, occurred in 3/14 (21.4%) patients, including gastro-intestinal paresis and hypertriglyceridemia. Three month outcomes were available for 12/14 (85.7%) patients, with 4 patients being seizure-free, and 3 others with decreased seizure frequency compared to pre-RSE baseline.This series suggests efficacy and safety of KD for treatment of pediatric RSE." @default.
• W2801690382 created "2018-05-17" @default.
• W2801690382 creator A5001406846 @default.
• W2801690382 creator A5002880520 @default.
• W2801690382 creator A5002920691 @default.
• W2801690382 creator A5015601225 @default.
• W2801690382 creator A5025949000 @default.
• W2801690382 creator A5036362648 @default.
• W2801690382 creator A5046645524 @default.
• W2801690382 creator A5058311554 @default.
• W2801690382 creator A5058860189 @default.
• W2801690382 creator A5059439153 @default.
• W2801690382 creator A5073300989 @default.
• W2801690382 creator A5074544711 @default.
• W2801690382 creator A5078339501 @default.
• W2801690382 creator A5080750482 @default.
• W2801690382 creator A5080946525 @default.
• W2801690382 creator A5090712549 @default.
• W2801690382 date "2018-08-01" @default.
• W2801690382 modified "2023-09-30" @default.
• W2801690382 title "Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus" @default.
• W2801690382 cites W1593211156 @default.
• W2801690382 cites W1803953876 @default.
• W2801690382 cites W1916100501 @default.
• W2801690382 cites W1965147078 @default.
• W2801690382 cites W1975009255 @default.
• W2801690382 cites W1982487768 @default.
• W2801690382 cites W1993891203 @default.
• W2801690382 cites W1999766340 @default.
• W2801690382 cites W2002098157 @default.
• W2801690382 cites W2002617050 @default.
• W2801690382 cites W2004842526 @default.
• W2801690382 cites W2029710021 @default.
• W2801690382 cites W2047900597 @default.
• W2801690382 cites W2055172838 @default.
• W2801690382 cites W2065956573 @default.
• W2801690382 cites W2067406665 @default.
• W2801690382 cites W2071085267 @default.
• W2801690382 cites W2071678082 @default.
• W2801690382 cites W2081262717 @default.
• W2801690382 cites W2096871605 @default.
• W2801690382 cites W2122546008 @default.
• W2801690382 cites W2129658473 @default.
• W2801690382 cites W2198063087 @default.
• W2801690382 cites W2285533538 @default.
• W2801690382 cites W2315273870 @default.
• W2801690382 cites W2494278506 @default.
• W2801690382 cites W2511309605 @default.
• W2801690382 cites W2586440357 @default.
• W2801690382 cites W340066840 @default.
• W2801690382 doi "https://doi.org/10.1016/j.eplepsyres.2018.04.012" @default.
• W2801690382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29727818" @default.
• W2801690382 hasPublicationYear "2018" @default.
• W2801690382 type Work @default.
• W2801690382 sameAs 2801690382 @default.
• W2801690382 citedByCount "36" @default.
• W2801690382 countsByYear W28016903822018 @default.
• W2801690382 countsByYear W28016903822019 @default.
• W2801690382 countsByYear W28016903822020 @default.
• W2801690382 countsByYear W28016903822021 @default.
• W2801690382 countsByYear W28016903822022 @default.
• W2801690382 countsByYear W28016903822023 @default.
• W2801690382 crossrefType "journal-article" @default.
• W2801690382 hasAuthorship W2801690382A5001406846 @default.
• W2801690382 hasAuthorship W2801690382A5002880520 @default.
• W2801690382 hasAuthorship W2801690382A5002920691 @default.
• W2801690382 hasAuthorship W2801690382A5015601225 @default.
• W2801690382 hasAuthorship W2801690382A5025949000 @default.
• W2801690382 hasAuthorship W2801690382A5036362648 @default.
• W2801690382 hasAuthorship W2801690382A5046645524 @default.
• W2801690382 hasAuthorship W2801690382A5058311554 @default.
• W2801690382 hasAuthorship W2801690382A5058860189 @default.
• W2801690382 hasAuthorship W2801690382A5059439153 @default.
• W2801690382 hasAuthorship W2801690382A5073300989 @default.
• W2801690382 hasAuthorship W2801690382A5074544711 @default.
• W2801690382 hasAuthorship W2801690382A5078339501 @default.
• W2801690382 hasAuthorship W2801690382A5080750482 @default.
• W2801690382 hasAuthorship W2801690382A5080946525 @default.
• W2801690382 hasAuthorship W2801690382A5090712549 @default.
• W2801690382 hasConcept C118552586 @default.
• W2801690382 hasConcept C119060515 @default.
• W2801690382 hasConcept C121332964 @default.
• W2801690382 hasConcept C126322002 @default.
• W2801690382 hasConcept C134018914 @default.
• W2801690382 hasConcept C142424586 @default.
• W2801690382 hasConcept C187212893 @default.
• W2801690382 hasConcept C197934379 @default.
• W2801690382 hasConcept C2776731943 @default.
• W2801690382 hasConcept C2777341932 @default.
• W2801690382 hasConcept C2778186239 @default.
• W2801690382 hasConcept C2778587478 @default.
• W2801690382 hasConcept C2780874087 @default.
• W2801690382 hasConcept C42219234 @default.
• W2801690382 hasConcept C555293320 @default.
• W2801690382 hasConcept C71924100 @default.
• W2801690382 hasConcept C87355193 @default.
• W2801690382 hasConcept C90924648 @default.
• W2801690382 hasConceptScore W2801690382C118552586 @default.

• next